Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank57
3Y CAGR-18.9%
5Y CAGR-14.4%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
-18.9%/yr
vs +69.2%/yr prior
5Y CAGR
-14.4%/yr
Recent deceleration
Acceleration
-88.2pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $61.88M | -36.3% |
| 2024 | $97.19M | +19.1% |
| 2023 | $81.64M | -29.7% |
| 2022 | $116.19M | -22.3% |
| 2021 | $149.54M | +11.0% |
| 2020 | $134.73M | +929.5% |
| 2019 | $13.09M | -7.7% |
| 2018 | $14.17M | +15.4% |
| 2017 | $12.29M | -72.0% |
| 2016 | $43.95M | - |